BELLINGS

Eli Lilly Just Announced a Major Acquisition. Here's What It Means.

The drug giant added to its immunotherapy portfolio.

The drug giant added to its immunotherapy portfolio.

BELLINGS Intelligence Score: 18

Why it matters

Eli Lilly's acquisition is a routine corporate expansion within the pharmaceutical sector, unlikely to materially affect credit markets or underwriting standards beyond the company and its immediate investors.

Sources